MIN-101

MIN-101 Suppliers list

Company Name:	TargetMol Chemicals Inc.
Tel:	+17819995354
Email:	marketing@targetmol.com
Products Intro:	Product Name:Roluperidone CAS:359625-79-9 Purity:97.77% Package:1mg;30USD\|5mg;58USD\|10mg;93USD Remarks:REAGENT;FOR LABORATORY USE ONLY

Company Name:	InvivoChem
Tel:	+1-708-310-1919 +1-13798911105
Email:	sales@invivochem.cn
Products Intro:	Product Name:Roluperidone CAS:359625-79-9 Purity:98% Package:5mg Remarks:V4698

Company Name:	Wuhan Topule Biopharmaceutical Co., Ltd
Tel:	+8618327326525
Email:	masar@topule.com
Products Intro:	Product Name:CYR-101; Roluperidone CAS:359625-79-9 Purity:0.98 Package:100mg;1g;500g Remarks:Topule Company operates with integrity and has its own laboratory, which supports packaging and customization. Payment will be made after the product has passed third-party testing

Company Name:	Aladdin Scientific
Tel:
Email:	tp@aladdinsci.com
Products Intro:	Product Name:Roluperidone CAS:359625-79-9 Purity:98% Package:$41.9/1mg;$91.9/5mg;$147.9/10mg;$263.9/25mg;$432.9/50mg;$870.9/100mg;Bulk packag Remarks:98%

Company Name:	Suzhou ARTK Medchem Co., Ltd.
Tel:	+86-512-68323658 +86-18168183658
Email:	sales1@artkmedchem.com
Products Intro:	Product Name:CYR-101 CAS:359625-79-9 Purity:0.98 Package:100KG;25KG;10KG;1KG

MIN-101 manufacturers

MIN-101 Basic information

Product Name:	MIN-101
Synonyms:	MIN-101;CYR-101;Roluperidone (CYR-101);MIN-101; MIN 101; MIN101; CYR-101; CYR 101; CYR101; MT-210; MT 210; MT210;;MT 210;MT210;MT-210;Roluperidone
CAS:	359625-79-9
MF:	C22H23FN2O2
MW:	366.43
EINECS:
Product Categories:	APIS
Mol File:	359625-79-9.mol

MIN-101 Chemical Properties

Safety Information

MSDS Information

MIN-101 Usage And Synthesis

Uses	Roluperidone (CYR-101) is a novel cyclic amide derivative that has high equipotent affinities for 5-HT2A and sigma-2 receptors (Ki of 7.53 nM and 8.19 nM for 5-HT2A and sigma-2, respectively).
IC 50	5-HT_2A Receptor: 7.53 nM (Ki); Sigma-2 Receptor: 8.19 nM (Ki)
References	[1] Davidson M, et al. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. Am J Psychiatry. 2017 Jul 28:appiajp201717010122. DOI:10.1176/appi.ajp.2017.17010122

MIN-101 Preparation Products And Raw materials

Tag:MIN-101(359625-79-9) Related Product Information

HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.